Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Tomasz M. Beer
Based on 105 articles published since 2008
||||
Expertise Level
The expertise of Tomasz M. Beer ranks in the
  • Top 0.025%
  • ... of 129,687 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 105 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Beer, T M   ·   Beer, Tomasz M
Work Locations
Details
Most likely:    Oregon Health Sciences University   Contact    
2018
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239. · Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239. · Computational Biology, Oregon Health & Science University, Portland, OR 97239. · Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109. · Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR 97239. · Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331. · Center for Health Research, Kaiser Permanente NW, Portland, OR 97227. · Pathology, Medstar Georgetown University Hospital, Washington, DC 20007. · Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057. · Research and Evaluation, Kaiser Permanente, Pasadena, CA 91101. · Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112. · Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239; · Pubmed 29581250
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Oregon Health & Science University, Portland, OR. · Pubmed 29125921
  • OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 S.W. Bond Avenue, CH14R, Portland, OR 97239, USA. Electronic address: · Department of Urology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: · Service D'Urologie, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200 Brussels, Belgium. Electronic address: · Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 633 N. St. Clair St., 19th Floor, Chicago, IL 60611, USA. Electronic address: · Astellas Pharma Inc, Sylviusweg 62, 2300 AH Leiden, The Netherlands. Electronic address: · Astellas Pharma Inc, Sylviusweg 62, 2300 AH Leiden, The Netherlands. Electronic address: · QuintilesIMS, Siriusdreef 10, 2132 WT Hoofddorp, The Netherlands. Electronic address: · QuintilesIMS, Sardenya 537, 08024 Barcelona, Spain. Electronic address: · Astellas Pharma Inc, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr., Chertsey, Surrey KT16 0RS, UK. Electronic address: · Pubmed 29096157
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. Electronic address: · Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Department of Medicine, University of California, San Francisco, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. · Biostatistics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. · Department of Urology, University of California, San Francisco, CA. · Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA. · Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. · Epic Biosciences, La Jolla, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA; Department of Urology, University of California, San Francisco, CA. · Pubmed 28655452
  • Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, C/Mallorca 183, 08036, Barcelona, Spain. · Astellas Pharma Global Development, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Astellas Medical Affairs, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr, Chertsey, Surrey, KT16 0PS, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 SW Bond Ave., CH14R, Portland, OR, 97239, USA. · Institut de Recherche Clinique (IREC), Cliniques Universitaires Saint Luc, Av Hippocrate, 10 - 1200 Bruxelles - Belgique, Brussels, Belgium. · Institut Gustave Roussy, University of Paris Sud, 114, rue Edouard-Vaillant, 94805, Villejuif Cedex, France. · Quintiles, Siriusdreef 10 Beukenhorst Zuid 2132, WT, Hoofddorp, The Netherlands. · Medivation, Inc., 525 Market St, Fl 36, San Francisco, CA, 94105, USA. · Astellas Medical Affairs, Global HEOR, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Pubmed 28645287
  • Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. Electronic address: · Duke University Department of Biostatistics, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. · Wake Forest University, Winston-Salem, NC, USA. · University of Washington, Seattle, WA, USA. · Pubmed 28502694
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Eugene D. Kwon, Mayo Clinic, Rochester, MN · Charles G. Drake, Johns Hopkins University, Baltimore, MD · Karim Fizazi, University of Paris-Sud, Villejuif · Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France · Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX · Vinod Ganju, Monash University, Melbourne, Victoria · Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia · Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia · Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada · Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland · Josep M. Piulats, Institut Català d'Oncologia, Barcelona · Javier Puente, Hospital Clínico San Carlos, Madrid, Spain · Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar · Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile · Dirk Jaeger, University Hospital, Heidelberg, Germany · Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil · Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico · Lisa Sengeløv, Herlev Hospital, Herlev, Denmark · M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT · Arvind Varma, DOCS Inc, New York, NY · Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam · and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
  • School of Medicine, School of Public Health, Oregon Health and Science University, Portland, OR, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Hospital and Specialty Medicine, VA Portland Health Care System, Portland, OR, USA. · Miraca Life Sciences, Irving, TX, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · Department of Urology, Oregon Health and Science University, Portland, OR, USA. · Department of Urology and Radiation Medicine, VA Portland Health Care System, Portland, OR, USA. · Pubmed 27480340
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. Electronic address: · Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Pathology, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, Duke University School of Medicine, Durham, North Carolina. · Department of Medicine, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Pubmed 28549709
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · School of Nursing, Oregon Health & Science University, Portland, Oregon. · Department of Medicine, Oregon Health & Science University, Portland, Oregon. · Pubmed 28263373
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
  • Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Quintiles, Hoofddorp, The Netherlands. · Astellas Pharma, Leiden, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medivation, San Francisco, CA, USA. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Cliniques universitaires Saint-Luc, Bruxelles, Belgium. · Astellas Medical Affairs, Global HEOR, Leiden, The Netherlands. · Pubmed 28045115
  • Knight Cancer Institute, Oregon Health & Science University, Portland2VA Portland Health Care System, Portland, Oregon. · Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 27812686
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Oregon Health & Science University, Portland, OR. · Oregon Health & Science University, Portland, OR · Pubmed 27400946
  • Division of Hematology/Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · VA Portland Health Care System, Portland, OR, USA. · Sidney Kimmel Comprehensive Cancer Center and the Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR, USA. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA. · Cell, Developmental, and Cancer Biology Department, Oregon Health and Science University, Portland, OR, USA. · Pubmed 27429197
  • Department of Urology, Nippon Medical School, Tokyo, Japan. · Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. · Department of Urology, Showa University Koto Toyosu Hospital, Tokyo, Japan. · Department of Urology, Kyoto University Hospital, Kyoto, Japan. · Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. · Department of Urology, Kinki University Faculty of Medicine, Higashiosaka City, Osaka, Japan. · Clinical Development, Medivation, San Francisco, California, USA. · Biostatistics, Astellas Pharma Global Development, Leiden, The Netherlands. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Urology, Chiba Cancer Center, Chiba, Japan. · Pubmed 27018069
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, U.S.A. · Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, U.S.A. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, U.S.A. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 27276681
  • Oregon Health &Science University Knight Cancer Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA. · Pubmed 26718107
  • Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. · School of Nursing, Oregon Health and Science University, Portland, OR, 97239, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. · School of Nursing, Oregon Health and Science University, Portland, OR, 97239, USA. · Pubmed 26715587
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Knight Cancer Institute at Oregon Health and Science University, Portland, OR. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25450031
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Portland VA Medical Center, Portland, OR; Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Hofstra North Shore-LIJ School of Medicine; The Feinstein Institute for Medical Research, Manhasset, NY. · University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL. · Hofstra North Shore-LIJ School of Medicine; The Feinstein Institute for Medical Research, Manhasset, NY. Electronic address: · Pubmed 25735198
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR; School of Nursing, Oregon Health & Science University, Portland, OR. Electronic address: · School of Nursing, Oregon Health & Science University, Portland, OR. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR; School of Nursing, Oregon Health & Science University, Portland, OR. · Department of Exercise and Sport Science, School of Biologic and Population Health, Oregon State University, Corvallis, OR. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR; School of Medicine, Oregon Health & Science University, Portland, OR. · Pubmed 25194450
2014
  • Cancer Commons, Palo Alto, CA. · Oregon Health and Science University, Knight Cancer Institute, Portland, OR. · Department of Urology and Comprehensive Cancer Center, University of California, Davis, CA. · Pubmed 25277175
  • Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. · Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. Electronic address: · Pubmed 25046532
  • Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology and Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, United States of America; Section of Urology, Portland VA Medical Center, Portland, Oregon, United States of America. · Department of Medicine, Oregon Health and Sciences University, Portland, Oregon, United States of America. · Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Pubmed 25198178
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Knight Cancer Institute, School of Nursing, Oregon Health and Science University, Portland, OR · Knight Cancer Institute, School of Medicine, Oregon Health and Science University, Portland, OR. · Pubmed 25002711
2013
  • Division of Hematology & Medical Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Pubmed 23896100
2012
  • Knight Cancer Institute, Oregon Health & Science University, Mail code CH14R, 3303 SW Bond Avenue, Portland, OR 97239, USA. · Pubmed 22850553
2011
  • Oregon Health & Science University Knight Cancer Institute, Portland, Oregon, USA. · Pubmed 21558406
2010
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97239, USA. · Pubmed 20494414
  • Knight Cancer Institute, Oregon Health and Science University, 3303 SW Bond Ave., Portland, OR 97239, USA. · Pubmed 20016365
2008
  • Oregon Health & Science University Cancer Institute, Portland, OR 97239, USA. · Pubmed 18824433
  • Division of Hematology & Medical Oncology, Oregon Health & Sciences University, Portland, OR 97239, USA. · Pubmed 18428198
2017
  • aDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine bDepartment of Urology, Yonsei University College of Medicine cDepartment of Urology, Seoul National University Bundang Hospital dDepartment of Urology, Samsung Medical Center, Seoul, Korea eProstate Center and Division of Urology, Chiba Cancer Center, Chiba fDepartment of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research gDepartment of Urology, Showa University Koto Toyosu Hospital, Tokyo, Japan hDepartment of Urology, National University Health System iUrology Centre, Singapore General Hospital, Singapore jMedical Affairs, Medivation, Inc., San Francisco, CA [Medivation was acquired by Pfizer Inc in September 2016] kBiostatistics, Astellas Pharma Europe B.V., Leiden, The Netherlands lDivision of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium mOHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR nDepartment of Urology, Nippon Medical School, Tokyo, Japan. · Pubmed 28682871
  • aSchool of Medicine bDepartment of Cell, Developmental and Cancer Biology cKnight Cancer Institute, Oregon Health and Science University Departments of dUrology and Radiation Medicine eSpecialty Medicine, VA Portland Health Care System, Portland, Oregon Departments of fImmunology gBreast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Departments of hMedicine iUrology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA. · Pubmed 27669423
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland · Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA · Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR · Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
  • a 1 Veterans Affairs Portland Health Care System, Portland, OR, USA. · Pubmed 26223224
  • Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon. · Pubmed 25417604
  • Portland Veterans Affairs Medical Center, OHSU Knight Cancer Institute , 3710 SW US Veterans Hospital Road, Portland, 97239 OR , USA +1 503 220 8262 ; +1 503 494 6197 ; · Pubmed 25687355
  • OHSU Knight Cancer Institute Oregon Health & Science University (OHSU), 3303 SW Bond Avenue, Portland, OR, 97239, USA, · Pubmed 25431127
2014
  • Portland VA Medical Center, Portland, OR, USA, · Pubmed 25387443
  • Authors' Affiliations: Department of Pathology, Providence Health System, Portland, Oregon. · Pubmed 24795352
  • 1School of Nursing, Oregon Health and Science University, Portland, OR; 2School of Medicine, Oregon Health and Science University, Portland, OR; and 3Knight Cancer Institute, Oregon Health and Science University, Portland, OR; 4Department of Exercise and Sport Science, School of Biologic and Population Health, Oregon State University, Corvallis, OR. · Pubmed 24500540
  • Authors' Affiliations: Knight Cancer Institute; Department of Public Health and Preventive Medicine; Knight Diagnostic Laboratories, Oregon Health and Science University; Portland VA Medical Center, Portland, Oregon; and Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington. · Pubmed 24352642
  • School of Nursing, Oregon Health & Science University, Mailcode: SN-ORD, Portland, OR, 97239, USA, · Pubmed 24337765
2013
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Pubmed 23817779
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA. · Pubmed 23977755
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Pubmed 23389923
  • Portland Veterans Affairs Medical Center, Portland, OR 97239, USA. · Pubmed 23374810
  • W. M. Keck Foundation High-Field MRI Laboratory, Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon 97239, USA. · Pubmed 22457233
2012
  • W.M. Keck Foundation High-Field MRI Laboratory, Advanced Imaging Research Center, Portland, OR 97239, USA. · Pubmed 22578558
  • School of Nursing, Oregon Health and Science University, Portland, OR 97239, United States. · Pubmed 22101224
  • Division of Hematology and Medical Oncology, Oregon Health and Science University (Sam Jackson Park Rd.), Portland, OR 97239, USA. · Pubmed 20207556
2011
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Mail Code L586, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. · Pubmed 21798396
  • Knight Cancer Institute, Oregon Health and Science University, Mail Code L586, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Pubmed 21498723
2010
  • Oregon Health & Science University, Portland, 97239, USA. · Pubmed 20231619
  • Division of Urology, Oregon Health and Science University, Portland Veterans Administration Medical Center, Portland, Oregon, USA. · Pubmed 20143429
  • Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon 97239, USA. · Pubmed 20388787
  • Division of Hematology and Medical Oncology and the Knight Cancer Institute, Oregon Health & Science University, CH-14R, 3303 SW Bond Ave, Portland, OR 97239, USA. · Pubmed 20383574
  • Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon 97239, USA. · Pubmed 19866475
2009
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA. · Pubmed 19111808
2008
  • Division of Hematology and Medical Oncology and OHSU Cancer Institute, Oregon Health and Science University, Portland, Oregon 97239, USA. · Pubmed 18342209
  • Oregon Health & Science University, Portland, OR 97239, USA. · Pubmed 18782306
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, CH-14R, 3303 SW Bond Avenue, Portland, OR 97239, USA. · Pubmed 18519790
Probable:    Miscellaneous cities in Oregon      
2016
  • School of Nursing, Oregon Health & Science University. · Knight Cancer Institute, Oregon Health & Science University. · Pubmed 26462060
2015
  • School of Nursing, Oregon Health and Science University, Portland. · Oregon Health and Science University in Portland. · Oregon State University in Corvallis. · Knight Cancer Institute at Oregon Health and Science University. · Pubmed 26148314
2009
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, OR, USA. · Pubmed 19366833
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 105 total) written by Tomasz M. Beer about Prostatic Neoplasms:

  • LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. 2018
  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Management of Anticoagulation in Patients With Prostate Cancer Receiving Enzalutamide. 2017
  • The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies. 2017
  • Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial. 2017
  • Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer. 2017
  • High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer. 2017
  • Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial. 2017
  • Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer. 2017
  • Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Tomasz M. Beer using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Oregon Health Sciences University
Miscellaneous cities in Oregon
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Oregon Health Sciences University
2018
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239. · Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239. · Computational Biology, Oregon Health & Science University, Portland, OR 97239. · Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109. · Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR 97239. · Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331. · Center for Health Research, Kaiser Permanente NW, Portland, OR 97227. · Pathology, Medstar Georgetown University Hospital, Washington, DC 20007. · Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057. · Research and Evaluation, Kaiser Permanente, Pasadena, CA 91101. · Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112. · Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239; · Pubmed 29581250
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Oregon Health & Science University, Portland, OR. · Pubmed 29125921
  • OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 S.W. Bond Avenue, CH14R, Portland, OR 97239, USA. Electronic address: · Department of Urology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: · Service D'Urologie, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200 Brussels, Belgium. Electronic address: · Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 633 N. St. Clair St., 19th Floor, Chicago, IL 60611, USA. Electronic address: · Astellas Pharma Inc, Sylviusweg 62, 2300 AH Leiden, The Netherlands. Electronic address: · Astellas Pharma Inc, Sylviusweg 62, 2300 AH Leiden, The Netherlands. Electronic address: · QuintilesIMS, Siriusdreef 10, 2132 WT Hoofddorp, The Netherlands. Electronic address: · QuintilesIMS, Sardenya 537, 08024 Barcelona, Spain. Electronic address: · Astellas Pharma Inc, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr., Chertsey, Surrey KT16 0RS, UK. Electronic address: · Pubmed 29096157
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. Electronic address: · Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Department of Medicine, University of California, San Francisco, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. · Biostatistics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. · Department of Urology, University of California, San Francisco, CA. · Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA. · Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. · Epic Biosciences, La Jolla, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA; Department of Urology, University of California, San Francisco, CA. · Pubmed 28655452
  • Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, C/Mallorca 183, 08036, Barcelona, Spain. · Astellas Pharma Global Development, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Astellas Medical Affairs, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr, Chertsey, Surrey, KT16 0PS, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 SW Bond Ave., CH14R, Portland, OR, 97239, USA. · Institut de Recherche Clinique (IREC), Cliniques Universitaires Saint Luc, Av Hippocrate, 10 - 1200 Bruxelles - Belgique, Brussels, Belgium. · Institut Gustave Roussy, University of Paris Sud, 114, rue Edouard-Vaillant, 94805, Villejuif Cedex, France. · Quintiles, Siriusdreef 10 Beukenhorst Zuid 2132, WT, Hoofddorp, The Netherlands. · Medivation, Inc., 525 Market St, Fl 36, San Francisco, CA, 94105, USA. · Astellas Medical Affairs, Global HEOR, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Pubmed 28645287
  • Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. Electronic address: · Duke University Department of Biostatistics, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. · Wake Forest University, Winston-Salem, NC, USA. · University of Washington, Seattle, WA, USA. · Pubmed 28502694
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Eugene D. Kwon, Mayo Clinic, Rochester, MN · Charles G. Drake, Johns Hopkins University, Baltimore, MD · Karim Fizazi, University of Paris-Sud, Villejuif · Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France · Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX · Vinod Ganju, Monash University, Melbourne, Victoria · Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia · Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia · Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada · Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland · Josep M. Piulats, Institut Català d'Oncologia, Barcelona · Javier Puente, Hospital Clínico San Carlos, Madrid, Spain · Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar · Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile · Dirk Jaeger, University Hospital, Heidelberg, Germany · Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil · Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico · Lisa Sengeløv, Herlev Hospital, Herlev, Denmark · M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT · Arvind Varma, DOCS Inc, New York, NY · Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam · and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
  • School of Medicine, School of Public Health, Oregon Health and Science University, Portland, OR, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Hospital and Specialty Medicine, VA Portland Health Care System, Portland, OR, USA. · Miraca Life Sciences, Irving, TX, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · Department of Urology, Oregon Health and Science University, Portland, OR, USA. · Department of Urology and Radiation Medicine, VA Portland Health Care System, Portland, OR, USA. · Pubmed 27480340
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. Electronic address: · Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Pathology, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, Duke University School of Medicine, Durham, North Carolina. · Department of Medicine, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Pubmed 28549709
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · School of Nursing, Oregon Health & Science University, Portland, Oregon. · Department of Medicine, Oregon Health & Science University, Portland, Oregon. · Pubmed 28263373
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
  • Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Quintiles, Hoofddorp, The Netherlands. · Astellas Pharma, Leiden, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medivation, San Francisco, CA, USA. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Cliniques universitaires Saint-Luc, Bruxelles, Belgium. · Astellas Medical Affairs, Global HEOR, Leiden, The Netherlands. · Pubmed 28045115
  • Knight Cancer Institute, Oregon Health & Science University, Portland2VA Portland Health Care System, Portland, Oregon. · Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 27812686
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Oregon Health & Science University, Portland, OR. · Oregon Health & Science University, Portland, OR · Pubmed 27400946
  • Division of Hematology/Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · VA Portland Health Care System, Portland, OR, USA. · Sidney Kimmel Comprehensive Cancer Center and the Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR, USA. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA. · Cell, Developmental, and Cancer Biology Department, Oregon Health and Science University, Portland, OR, USA. · Pubmed 27429197
  • Department of Urology, Nippon Medical School, Tokyo, Japan. · Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. · Department of Urology, Showa University Koto Toyosu Hospital, Tokyo, Japan. · Department of Urology, Kyoto University Hospital, Kyoto, Japan. · Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. · Department of Urology, Kinki University Faculty of Medicine, Higashiosaka City, Osaka, Japan. · Clinical Development, Medivation, San Francisco, California, USA. · Biostatistics, Astellas Pharma Global Development, Leiden, The Netherlands. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Urology, Chiba Cancer Center, Chiba, Japan. · Pubmed 27018069
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, U.S.A. · Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, U.S.A. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, U.S.A. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 27276681
  • Oregon Health &Science University Knight Cancer Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA. · Pubmed 26718107
  • Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. · School of Nursing, Oregon Health and Science University, Portland, OR, 97239, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. · School of Nursing, Oregon Health and Science University, Portland, OR, 97239, USA. · Pubmed 26715587
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Knight Cancer Institute at Oregon Health and Science University, Portland, OR. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25450031
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Portland VA Medical Center, Portland, OR; Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Hofstra North Shore-LIJ School of Medicine; The Feinstein Institute for Medical Research, Manhasset, NY. · University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL. · Hofstra North Shore-LIJ School of Medicine; The Feinstein Institute for Medical Research, Manhasset, NY. Electronic address: · Pubmed 25735198
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR; School of Nursing, Oregon Health & Science University, Portland, OR. Electronic address: · School of Nursing, Oregon Health & Science University, Portland, OR. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR; School of Nursing, Oregon Health & Science University, Portland, OR. · Department of Exercise and Sport Science, School of Biologic and Population Health, Oregon State University, Corvallis, OR. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR; School of Medicine, Oregon Health & Science University, Portland, OR. · Pubmed 25194450
2014
  • Cancer Commons, Palo Alto, CA. · Oregon Health and Science University, Knight Cancer Institute, Portland, OR. · Department of Urology and Comprehensive Cancer Center, University of California, Davis, CA. · Pubmed 25277175
  • Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. · Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. Electronic address: · Pubmed 25046532
  • Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology and Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, United States of America; Section of Urology, Portland VA Medical Center, Portland, Oregon, United States of America. · Department of Medicine, Oregon Health and Sciences University, Portland, Oregon, United States of America. · Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Pubmed 25198178
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Knight Cancer Institute, School of Nursing, Oregon Health and Science University, Portland, OR · Knight Cancer Institute, School of Medicine, Oregon Health and Science University, Portland, OR. · Pubmed 25002711
2013
  • Division of Hematology & Medical Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Pubmed 23896100
2012
  • Knight Cancer Institute, Oregon Health & Science University, Mail code CH14R, 3303 SW Bond Avenue, Portland, OR 97239, USA. · Pubmed 22850553
2011
  • Oregon Health & Science University Knight Cancer Institute, Portland, Oregon, USA. · Pubmed 21558406
2010
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97239, USA. · Pubmed 20494414
  • Knight Cancer Institute, Oregon Health and Science University, 3303 SW Bond Ave., Portland, OR 97239, USA. · Pubmed 20016365
2008
  • Oregon Health & Science University Cancer Institute, Portland, OR 97239, USA. · Pubmed 18824433
  • Division of Hematology & Medical Oncology, Oregon Health & Sciences University, Portland, OR 97239, USA. · Pubmed 18428198
2017
  • aDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine bDepartment of Urology, Yonsei University College of Medicine cDepartment of Urology, Seoul National University Bundang Hospital dDepartment of Urology, Samsung Medical Center, Seoul, Korea eProstate Center and Division of Urology, Chiba Cancer Center, Chiba fDepartment of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research gDepartment of Urology, Showa University Koto Toyosu Hospital, Tokyo, Japan hDepartment of Urology, National University Health System iUrology Centre, Singapore General Hospital, Singapore jMedical Affairs, Medivation, Inc., San Francisco, CA [Medivation was acquired by Pfizer Inc in September 2016] kBiostatistics, Astellas Pharma Europe B.V., Leiden, The Netherlands lDivision of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium mOHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR nDepartment of Urology, Nippon Medical School, Tokyo, Japan. · Pubmed 28682871
  • aSchool of Medicine bDepartment of Cell, Developmental and Cancer Biology cKnight Cancer Institute, Oregon Health and Science University Departments of dUrology and Radiation Medicine eSpecialty Medicine, VA Portland Health Care System, Portland, Oregon Departments of fImmunology gBreast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Departments of hMedicine iUrology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA. · Pubmed 27669423
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland · Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA · Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR · Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
  • a 1 Veterans Affairs Portland Health Care System, Portland, OR, USA. · Pubmed 26223224
  • Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon. · Pubmed 25417604
  • Portland Veterans Affairs Medical Center, OHSU Knight Cancer Institute , 3710 SW US Veterans Hospital Road, Portland, 97239 OR , USA +1 503 220 8262 ; +1 503 494 6197 ; · Pubmed 25687355
  • OHSU Knight Cancer Institute Oregon Health & Science University (OHSU), 3303 SW Bond Avenue, Portland, OR, 97239, USA, · Pubmed 25431127
2014
  • Portland VA Medical Center, Portland, OR, USA, · Pubmed 25387443
  • Authors' Affiliations: Department of Pathology, Providence Health System, Portland, Oregon. · Pubmed 24795352
  • 1School of Nursing, Oregon Health and Science University, Portland, OR; 2School of Medicine, Oregon Health and Science University, Portland, OR; and 3Knight Cancer Institute, Oregon Health and Science University, Portland, OR; 4Department of Exercise and Sport Science, School of Biologic and Population Health, Oregon State University, Corvallis, OR. · Pubmed 24500540
  • Authors' Affiliations: Knight Cancer Institute; Department of Public Health and Preventive Medicine; Knight Diagnostic Laboratories, Oregon Health and Science University; Portland VA Medical Center, Portland, Oregon; and Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington. · Pubmed 24352642
  • School of Nursing, Oregon Health & Science University, Mailcode: SN-ORD, Portland, OR, 97239, USA, · Pubmed 24337765
2013
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Pubmed 23817779
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA. · Pubmed 23977755
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Pubmed 23389923
  • Portland Veterans Affairs Medical Center, Portland, OR 97239, USA. · Pubmed 23374810
  • W. M. Keck Foundation High-Field MRI Laboratory, Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon 97239, USA. · Pubmed 22457233
2012
  • W.M. Keck Foundation High-Field MRI Laboratory, Advanced Imaging Research Center, Portland, OR 97239, USA. · Pubmed 22578558
  • School of Nursing, Oregon Health and Science University, Portland, OR 97239, United States. · Pubmed 22101224
  • Division of Hematology and Medical Oncology, Oregon Health and Science University (Sam Jackson Park Rd.), Portland, OR 97239, USA. · Pubmed 20207556
2011
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Mail Code L586, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. · Pubmed 21798396
  • Knight Cancer Institute, Oregon Health and Science University, Mail Code L586, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Pubmed 21498723
2010
  • Oregon Health & Science University, Portland, 97239, USA. · Pubmed 20231619
  • Division of Urology, Oregon Health and Science University, Portland Veterans Administration Medical Center, Portland, Oregon, USA. · Pubmed 20143429
  • Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon 97239, USA. · Pubmed 20388787
  • Division of Hematology and Medical Oncology and the Knight Cancer Institute, Oregon Health & Science University, CH-14R, 3303 SW Bond Ave, Portland, OR 97239, USA. · Pubmed 20383574
  • Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon 97239, USA. · Pubmed 19866475
2009
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA. · Pubmed 19111808
2008
  • Division of Hematology and Medical Oncology and OHSU Cancer Institute, Oregon Health and Science University, Portland, Oregon 97239, USA. · Pubmed 18342209
  • Oregon Health & Science University, Portland, OR 97239, USA. · Pubmed 18782306
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, CH-14R, 3303 SW Bond Avenue, Portland, OR 97239, USA. · Pubmed 18519790
Miscellaneous cities in Oregon
2016
  • School of Nursing, Oregon Health & Science University. · Knight Cancer Institute, Oregon Health & Science University. · Pubmed 26462060
2015
  • School of Nursing, Oregon Health and Science University, Portland. · Oregon Health and Science University in Portland. · Oregon State University in Corvallis. · Knight Cancer Institute at Oregon Health and Science University. · Pubmed 26148314
2009
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, OR, USA. · Pubmed 19366833
Unspecified
2014
31 Other Locations Show
Yearly article counts 121111514966976
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.